AI

The landscape of cancer care is on the brink of a significant transformation due to technological advancements, specifically artificial intelligence (AI). Recently, a consortium of leading cancer care institutions has banded together to form the Cancer AI Alliance (CAIA), fueled by considerable financial backing to harness AI’s capabilities in enhancing precision medicine. This initiative, supported
Artificial General Intelligence, commonly referred to as AGI, remains one of the most enigmatic frontiers in the field of artificial intelligence. While companies like OpenAI are investing vast resources—recently raising $6.6 billion—to achieve this ambitious goal, the very essence of AGI poses perplexing questions that experts struggle to answer. The term AGI is often bandied